corpus.blog
56,966 blogs · [ { "id": "01a0d7f8-4d10-7283-bd92-852f60077af9", "title": "Zucara’s ZT-01: what could taking the brake off glucagon do?", "url": "https://www.diabettech.com/too-much-too-little-at-the-wrong-time-zucaras-zt-01-and-the-glucagon-problem-in-type-1-diabetes/?utm_source=rss&utm_medium=rss&utm_campaign=too-much-too-little-at-the-wrong-time-zucaras-zt-01-and-the-glucagon-problem-in-type-1-diabetes", "published_at": "2026-09-23T13:36:58+00:00" }, { "id": "01a0d7f8-4d10-7283-bd92-852f60980325", "title": "More Bolus, Less Basal: What Happens When oref Loops Run More Frequently", "url": "https://www.diabettech.com/more-bolus-less-basal-what-happens-when-oref-loops-run-more-frequently/?utm_source=rss&utm_medium=rss&utm_campaign=more-bolus-less-basal-what-happens-when-oref-loops-run-more-frequently", "published_at": "2026-09-18T12:30:00+00:00" }, { "id": "01a0b0c2-2fe5-729b-88f8-9f80bcb594cb", "title": "Your CGM Knows You Ate. It Can’t Tell What You Ate.", "url": "https://www.diabettech.com/your-cgm-knows-you-ate-it-cant-tell-what-you-ate/?utm_source=rss&utm_medium=rss&utm_campaign=your-cgm-knows-you-ate-it-cant-tell-what-you-ate", "published_at": "2026-09-15T12:30:00+00:00" }, { "id": "01a0876c-7dad-732b-82fc-138726635ed1", "title": "Beyond Carb Counting: Boost’s Evolution — and the Limits of “Fully Closed Loop”", "url": "https://www.diabettech.com/beyond-carb-counting-boosts-evolution-and-the-limits-of-fully-closed-loop/?utm_source=rss&utm_medium=rss&utm_campaign=beyond-carb-counting-boosts-evolution-and-the-limits-of-fully-closed-loop", "published_at": "2026-09-07T12:00:00+00:00" }, { "id": "01a0876c-7dae-704a-9719-e12926032239", "title": "Bolt AI into your loop and you might just have become a medical device manufacturer", "url": "https://www.diabettech.com/bolt-ai-into-your-loop-and-you-might-just-have-become-a-medical-device-manufacturer/?utm_source=rss&utm_medium=rss&utm_campaign=bolt-ai-into-your-loop-and-you-might-just-have-become-a-medical-device-manufacturer", "published_at": "2026-08-28T16:12:51+00:00" }, { "id": "01a0876c-7dae-704a-9719-e12926f7e899", "title": "The world’s first digital endo that asks AI to fix your AID settings, and why you should keep your money.", "url": "https://www.diabettech.com/the-worlds-first-digital-endo-that-asks-ai-to-fix-your-aid-settings-and-why-you-should-keep-your-money/?utm_source=rss&utm_medium=rss&utm_campaign=the-worlds-first-digital-endo-that-asks-ai-to-fix-your-aid-settings-and-why-you-should-keep-your-money", "published_at": "2026-08-24T12:33:00+00:00" }, { "id": "01a0876c-7dae-704a-9719-e129274dd543", "title": "A world of pure imagination: AI, diabetes and the data we can’t get at", "url": "https://www.diabettech.com/a-world-of-pure-imagination-ai-diabetes-and-the-data-we-cant-get-at-2/?utm_source=rss&utm_medium=rss&utm_campaign=a-world-of-pure-imagination-ai-diabetes-and-the-data-we-cant-get-at-2", "published_at": "2026-08-06T12:45:27+00:00" }, { "id": "01a0876c-7dae-704a-9719-e129275ad622", "title": "Why is the cheese sandwich the downfall of AI carb counting, even with “3D scanning”?", "url": "https://www.diabettech.com/why-is-the-cheese-sandwich-the-downfall-of-ai-carb-counting/?utm_source=rss&utm_medium=rss&utm_campaign=why-is-the-cheese-sandwich-the-downfall-of-ai-carb-counting", "published_at": "2026-06-11T11:54:51+00:00" }, { "id": "01a0876c-7dae-704a-9719-e1292763ef02", "title": "The Libre Duo. A platform prototype to move care from the hospital to the home?", "url": "https://www.diabettech.com/the-libre-duo-a-platform-to-move-care-from-the-hospital-to-the-home/?utm_source=rss&utm_medium=rss&utm_campaign=the-libre-duo-a-platform-to-move-care-from-the-hospital-to-the-home", "published_at": "2026-06-01T11:30:21+00:00" }, { "id": "01a0876c-7dae-704a-9719-e12928561d04", "title": "Five AI models, three users, one finding: the settings came from the textbook, not the data", "url": "https://www.diabettech.com/five-ai-models-three-users-one-finding-the-settings-came-from-the-textbook-not-the-data/?utm_source=rss&utm_medium=rss&utm_campaign=five-ai-models-three-users-one-finding-the-settings-came-from-the-textbook-not-the-data", "published_at": "2026-04-22T13:00:00+00:00" }, { "id": "01a0876c-7dae-704a-9719-e1292882fec3", "title": "I Asked AI to Count My Carbs 27,000 Times. It Couldn’t Give Me the Same Answer Twice.", "url": "https://www.diabettech.com/i-asked-ai-to-count-my-carbs-27000-times-it-couldnt-give-me-the-same-answer-twice/?utm_source=rss&utm_medium=rss&utm_campaign=i-asked-ai-to-count-my-carbs-27000-times-it-couldnt-give-me-the-same-answer-twice", "published_at": "2026-04-15T12:30:00+00:00" }, { "id": "01a0876c-7dae-704a-9719-e129292bf647", "title": "The Daily Bolus: The Triple Agonist Showdown & Surprising GLP-1 Wins in Type 1 Diabetes", "url": "https://www.diabettech.com/the-daily-bolus-the-triple-agonist-showdown-surprising-glp-1-wins-in-type-1-diabetes/?utm_source=rss&utm_medium=rss&utm_campaign=the-daily-bolus-the-triple-agonist-showdown-surprising-glp-1-wins-in-type-1-diabetes", "published_at": "2026-03-26T23:06:43+00:00" }, { "id": "01a0876c-7dae-704a-9719-e129296e3f4e", "title": "100% Insulin Independence: Why Eledon’s Breakthrough is a Pillar, Not a Cure", "url": "https://www.diabettech.com/100-insulin-independence-why-eledons-breakthrough-is-a-pillar-not-a-cure/?utm_source=rss&utm_medium=rss&utm_campaign=100-insulin-independence-why-eledons-breakthrough-is-a-pillar-not-a-cure", "published_at": "2026-03-03T13:00:00+00:00" }, { "id": "01a0c507-e7c5-715b-ace1-ac7ed3ccf789", "title": "Explore a Decade of Diabetes Insights with Diabettech AI", "url": "https://www.diabettech.com/introducing-diabettech-ai/?utm_source=rss&utm_medium=rss&utm_campaign=introducing-diabettech-ai", "published_at": "2026-02-25T10:00:34+00:00" }, { "id": "01a0c507-e7c5-715b-ace1-ac7ed4b8b81d", "title": "The Daily Bolus: Red Cell Sponges, Microbiome Signatures, and Cyborg Cells", "url": "https://www.diabettech.com/the-daily-bolus-red-cell-sponges-microbiome-signatures-and-cyborg-cells/?utm_source=rss&utm_medium=rss&utm_campaign=the-daily-bolus-red-cell-sponges-microbiome-signatures-and-cyborg-cells", "published_at": "2026-02-20T16:56:57+00:00" }, { "id": "01a0c507-e7c5-715b-ace1-ac7ed4e874d1", "title": "Now We Know What a Type 1 Cure Could Look Like", "url": "https://www.diabettech.com/now-we-know-what-a-type-1-cure-could-look-like/?utm_source=rss&utm_medium=rss&utm_campaign=now-we-know-what-a-type-1-cure-could-look-like", "published_at": "2026-02-14T22:51:43+00:00" }, { "id": "01a0c507-e7c5-715b-ace1-ac7ed4fd8d49", "title": "The Daily Bolus: Retinopathy Pills, Diabetes Risk Watches, and Immune Fixes for Insulin Resistance", "url": "https://www.diabettech.com/the-daily-bolus-retinopathy-pills-diabetes-risk-watches-and-immune-fixes-for-insulin-resistance/?utm_source=rss&utm_medium=rss&utm_campaign=the-daily-bolus-retinopathy-pills-diabetes-risk-watches-and-immune-fixes-for-insulin-resistance", "published_at": "2026-02-14T18:38:49+00:00" }, { "id": "01a0c507-e7c5-715b-ace1-ac7ed5716fc9", "title": "The Daily Bolus: Early Warnings, Genetic Cloaks, and the Seven-Year Shield", "url": "https://www.diabettech.com/the-daily-bolus-early-warnings-genetic-cloaks-and-the-seven-year-shield/?utm_source=rss&utm_medium=rss&utm_campaign=the-daily-bolus-early-warnings-genetic-cloaks-and-the-seven-year-shield", "published_at": "2026-02-05T14:43:47+00:00" }, { "id": "01a0c507-e7c5-715b-ace1-ac7ed61128d1", "title": "The Daily Bolus: Mechanism over metrics, biology over dashboards", "url": "https://www.diabettech.com/the-daily-bolus-mechanism-over-metrics-biology-over-dashboards/?utm_source=rss&utm_medium=rss&utm_campaign=the-daily-bolus-mechanism-over-metrics-biology-over-dashboards", "published_at": "2026-01-30T16:48:52+00:00" }, { "id": "01a0c507-e7c5-715b-ace1-ac7ed649e12c", "title": "The Daily Bolus: Et tu, B Cells?", "url": "https://www.diabettech.com/the-daily-bolus-et-tu-b-cells/?utm_source=rss&utm_medium=rss&utm_campaign=the-daily-bolus-et-tu-b-cells", "published_at": "2026-01-21T09:44:01+00:00" }, { "id": "01a0c507-e7c5-715b-ace1-ac7ed6f2c840", "title": "What If Type 1 Diabetes Was Treatable — If You Found It Early Enough?", "url": "https://www.diabettech.com/what-if-type-1-diabetes-was-treatable-if-you-found-it-early-enough/?utm_source=rss&utm_medium=rss&utm_campaign=what-if-type-1-diabetes-was-treatable-if-you-found-it-early-enough", "published_at": "2026-01-19T17:00:55+00:00" }, { "id": "01a0c518-8cd2-7026-959a-9ea5398fc081", "title": "The Daily Bolus: What happened over the weekend?", "url": "https://www.diabettech.com/the-daily-bolus-what-happened-over-the-weekend/?utm_source=rss&utm_medium=rss&utm_campaign=the-daily-bolus-what-happened-over-the-weekend", "published_at": "2026-01-19T11:03:51+00:00" }, { "id": "01a0c518-8cd2-7026-959a-9ea53a10ac71", "title": "A “twiist” of Fate: Why Sequel is Moving Beyond Tidepool to Embrace Diabeloop", "url": "https://www.diabettech.com/a-twiist-of-fate-why-sequel-is-moving-beyond-tidepool-to-embrace-diabeloop/?utm_source=rss&utm_medium=rss&utm_campaign=a-twiist-of-fate-why-sequel-is-moving-beyond-tidepool-to-embrace-diabeloop", "published_at": "2026-01-15T08:30:29+00:00" }, { "id": "01a0c518-8cd2-7026-959a-9ea53a6d7d2a", "title": "The Daily Bolus: Interoperability, AI, and Enhanced Glycemic Insights", "url": "https://www.diabettech.com/the-daily-bolus-interoperability-ai-and-enhanced-glycemic-insights/?utm_source=rss&utm_medium=rss&utm_campaign=the-daily-bolus-interoperability-ai-and-enhanced-glycemic-insights", "published_at": "2026-01-13T16:28:58+00:00" }, { "id": "01a0c518-8cd2-7026-959a-9ea53ac39cc4", "title": "Introducing The Daily Bolus: Parsing the Signal from the Noise", "url": "https://www.diabettech.com/introducing-the-daily-bolus-parsing-the-signal-from-the-noise/?utm_source=rss&utm_medium=rss&utm_campaign=introducing-the-daily-bolus-parsing-the-signal-from-the-noise", "published_at": "2026-01-13T16:00:10+00:00" }, { "id": "01a0c518-8cd2-7026-959a-9ea53ba8aa1a", "title": "ChatGPT Health: Promise, Practicality, and the Reality for People with Diabetes", "url": "https://www.diabettech.com/chatgpt-health-promise-practicality-and-the-reality-for-people-with-diabetes/?utm_source=rss&utm_medium=rss&utm_campaign=chatgpt-health-promise-practicality-and-the-reality-for-people-with-diabetes", "published_at": "2026-01-12T18:44:38+00:00" }, { "id": "01a0c518-8cd2-7026-959a-9ea53c340951", "title": "Unauthorised Use of Nine Sensor Samba Data in Commercial Marketing", "url": "https://www.diabettech.com/unauthorised-use-of-nine-sensor-samba-data-in-commercial-marketing/?utm_source=rss&utm_medium=rss&utm_campaign=unauthorised-use-of-nine-sensor-samba-data-in-commercial-marketing", "published_at": "2025-10-31T11:30:10+00:00" }, { "id": "01a0c518-8cd2-7026-959a-9ea53ce277f9", "title": "A pump update and then… Something changed!", "url": "https://www.diabettech.com/from-insight-to-dana-i-an-unexpected-change-in-my-tdd/?utm_source=rss&utm_medium=rss&utm_campaign=from-insight-to-dana-i-an-unexpected-change-in-my-tdd", "published_at": "2025-09-23T17:30:58+00:00" }, { "id": "01a0c518-8cd2-7026-959a-9ea53d263142", "title": "The Nine Sensor Samba: How do the Consensus Error Grids stack up?", "url": "https://www.diabettech.com/the-nine-sensor-samba-how-do-the-consensus-error-grids-stack-up/?utm_source=rss&utm_medium=rss&utm_campaign=the-nine-sensor-samba-how-do-the-consensus-error-grids-stack-up", "published_at": "2025-09-15T13:30:00+00:00" }, { "id": "01a0c518-8cd2-7026-959a-9ea53dce05be", "title": "The nine sensor samba: Results revealed", "url": "https://www.diabettech.com/the-nine-sensor-samba-results-revealed/?utm_source=rss&utm_medium=rss&utm_campaign=the-nine-sensor-samba-results-revealed", "published_at": "2025-09-09T13:30:00+00:00" }, { "id": "01a0c518-8cd2-7026-959a-9ea53e724389", "title": "The Nine Sensor Samba — A Sneak Peek at Simultaneous CGM Testing", "url": "https://www.diabettech.com/nine-cgms-tested-together-sneak-peek-of-the-nine-sensor-samba-diabettech/?utm_source=rss&utm_medium=rss&utm_campaign=nine-cgms-tested-together-sneak-peek-of-the-nine-sensor-samba-diabettech", "published_at": "2025-08-15T13:30:53+00:00" }, { "id": "01a0c523-7cc9-723e-ae17-3ca695abb59f", "title": "Beyond Snaq-qing. Digesting your glucose patterns.", "url": "https://www.diabettech.com/beyond-snaq-qing-digesting-your-glucose-patterns/?utm_source=rss&utm_medium=rss&utm_campaign=beyond-snaq-qing-digesting-your-glucose-patterns", "published_at": "2025-08-12T13:30:06+00:00" }, { "id": "01a0c523-7cc9-723e-ae17-3ca6961f5ccb", "title": "Snaq. A diabetes AI to help you carb count. Badly.", "url": "https://www.diabettech.com/snaq-a-diabetes-ai-to-help-you-carb-count-badly/?utm_source=rss&utm_medium=rss&utm_campaign=snaq-a-diabetes-ai-to-help-you-carb-count-badly", "published_at": "2025-08-08T13:30:00+00:00" }, { "id": "01a0c523-7cc9-723e-ae17-3ca696c5c96e", "title": "In conversation with… Unpacking the “Why” Behind the Errors", "url": "https://www.diabettech.com/in-conversation-with-unpacking-the-why-behind-the-errors/?utm_source=rss&utm_medium=rss&utm_campaign=in-conversation-with-unpacking-the-why-behind-the-errors", "published_at": "2025-07-21T13:15:17+00:00" }, { "id": "01a0c523-7cc9-723e-ae17-3ca697554208", "title": "In conversation with… File uploads and interpretation. Where the wheels fall off!", "url": "https://www.diabettech.com/in-conversation-with-file-uploads-and-interpretation-where-the-wheels-fall-off/?utm_source=rss&utm_medium=rss&utm_campaign=in-conversation-with-file-uploads-and-interpretation-where-the-wheels-fall-off", "published_at": "2025-07-18T13:30:13+00:00" }, { "id": "01a0c523-7cc9-723e-ae17-3ca697787061", "title": "In Conversation with…. Reviewing user data and system settings using AI", "url": "https://www.diabettech.com/in-conversation-with-data-analysis-with-ai-diving-deep-into-nightscout-insights/?utm_source=rss&utm_medium=rss&utm_campaign=in-conversation-with-data-analysis-with-ai-diving-deep-into-nightscout-insights", "published_at": "2025-07-14T13:30:05+00:00" }, { "id": "01a0c523-7cc9-723e-ae17-3ca697c39d61", "title": "In Conversation with…. Carb Counting with AI: A Deep Dive into How Different Models Stack Up", "url": "https://www.diabettech.com/in-conversation-with-carb-counting-with-ai-a-deep-dive-into-how-different-models-stack-up/?utm_source=rss&utm_medium=rss&utm_campaign=in-conversation-with-carb-counting-with-ai-a-deep-dive-into-how-different-models-stack-up", "published_at": "2025-07-07T14:00:36+00:00" }, { "id": "01a0c523-7cc9-723e-ae17-3ca697ea7e2c", "title": "In conversation with… Factual questions for Large Language Models", "url": "https://www.diabettech.com/in-conversation-with-factual-questions-for-large-language-models/?utm_source=rss&utm_medium=rss&utm_campaign=in-conversation-with-factual-questions-for-large-language-models", "published_at": "2025-06-21T13:30:00+00:00" }, { "id": "01a0c523-7cc9-723e-ae17-3ca6987b15c6", "title": "In conversation with… the questions", "url": "https://www.diabettech.com/in-conversation-with-the-questions/?utm_source=rss&utm_medium=rss&utm_campaign=in-conversation-with-the-questions", "published_at": "2025-06-19T13:00:26+00:00" }, { "id": "01a0c523-7cc9-723e-ae17-3ca698b087fe", "title": "In conversation with…. How effective are large language models at giving diabetes advice?", "url": "https://www.diabettech.com/in-conversation-with-how-effective-are-large-language-models-at-giving-diabetes-advice/?utm_source=rss&utm_medium=rss&utm_campaign=in-conversation-with-how-effective-are-large-language-models-at-giving-diabetes-advice", "published_at": "2025-06-13T13:00:47+00:00" }, { "id": "01a0c523-7cc9-723e-ae17-3ca699382c55", "title": "Beyond Blood Sugar: Could incretins shield against diabetes complications?", "url": "https://www.diabettech.com/beyond-blood-sugar-could-incretins-shield-against-diabetes-complications-2/?utm_source=rss&utm_medium=rss&utm_campaign=beyond-blood-sugar-could-incretins-shield-against-diabetes-complications-2", "published_at": "2025-06-11T12:30:08+00:00" }, { "id": "01a0c52e-fafb-7058-af02-eaa734c816e1", "title": "Medtronic, Ypsomed, and the Diabetes Device Shake-Up: Spin-Offs, Strategy, and the Future of Diabetes Tech", "url": "https://www.diabettech.com/medtronic-ypsomed-and-the-diabetes-device-shake-up-spin-offs-strategy-and-the-future-of-diabetes-tech/?utm_source=rss&utm_medium=rss&utm_campaign=medtronic-ypsomed-and-the-diabetes-device-shake-up-spin-offs-strategy-and-the-future-of-diabetes-tech", "published_at": "2025-05-22T12:30:59+00:00" }, { "id": "01a0c52e-fafb-7058-af02-eaa734f3c9fb", "title": "It’s been a while…", "url": "https://www.diabettech.com/its-been-a-while/?utm_source=rss&utm_medium=rss&utm_campaign=its-been-a-while", "published_at": "2025-05-10T12:30:24+00:00" }, { "id": "01a0c52e-fafb-7058-af02-eaa735a32094", "title": "MARD wars. More craziness in the world of CGM marketing from ATTD", "url": "https://www.diabettech.com/mard-wars-more-craziness-in-the-world-of-cgm-marketing-from-attd/?utm_source=rss&utm_medium=rss&utm_campaign=mard-wars-more-craziness-in-the-world-of-cgm-marketing-from-attd", "published_at": "2025-03-26T13:10:00+00:00" }, { "id": "01a0c52e-fafb-7058-af02-eaa73614b532", "title": "It’s ATTD again, and here’s another CGM accuracy study…", "url": "https://www.diabettech.com/its-attd-again-and-heres-another-cgm-accuracy-study/?utm_source=rss&utm_medium=rss&utm_campaign=its-attd-again-and-heres-another-cgm-accuracy-study", "published_at": "2025-03-20T11:50:00+00:00" }, { "id": "01a0c52e-fafb-7058-af02-eaa73714735b", "title": "Holidays. Even from T1D?", "url": "https://www.diabettech.com/holidays-even-from-t1d/?utm_source=rss&utm_medium=rss&utm_campaign=holidays-even-from-t1d", "published_at": "2025-03-02T14:00:48+00:00" }, { "id": "01a0c52e-fafb-7058-af02-eaa737817bd5", "title": "CGM: Is “More” always better? Abbott’s Libres. More Data – part 2", "url": "https://www.diabettech.com/cgm-is-more-always-better-abbotts-libres-more-data-part-2/?utm_source=rss&utm_medium=rss&utm_campaign=cgm-is-more-always-better-abbotts-libres-more-data-part-2", "published_at": "2025-02-05T15:00:45+00:00" }, { "id": "01a0c52e-fafb-7058-af02-eaa737ef1c1b", "title": "CGM: Is “More” always better? Abbott’s Libres. More Data – part 1", "url": "https://www.diabettech.com/cgm-is-more-always-better-abbotts-libres-more-data/?utm_source=rss&utm_medium=rss&utm_campaign=cgm-is-more-always-better-abbotts-libres-more-data", "published_at": "2025-02-04T16:00:52+00:00" }, { "id": "01a0c52e-fafb-7058-af02-eaa738ecc221", "title": "CGM: Is “More” always better? Dexcom’s G7. More Accurate", "url": "https://www.diabettech.com/cgm-is-more-always-better-dexcoms-g7-more-accurate/?utm_source=rss&utm_medium=rss&utm_campaign=cgm-is-more-always-better-dexcoms-g7-more-accurate", "published_at": "2025-02-01T14:06:08+00:00" }, { "id": "01a0c52e-fafb-7058-af02-eaa738fa5e10", "title": "CGM: Is “More” always better?", "url": "https://www.diabettech.com/cgm-is-more-always-better/?utm_source=rss&utm_medium=rss&utm_campaign=cgm-is-more-always-better", "published_at": "2025-01-30T18:55:44+00:00" }, { "id": "01a0c52e-fafb-7058-af02-eaa7392e40d2", "title": "Location, location, location. Does cannula site affect AID performance?", "url": "https://www.diabettech.com/location-location-location-does-cannula-site-affect-aid-performance/?utm_source=rss&utm_medium=rss&utm_campaign=location-location-location-does-cannula-site-affect-aid-performance", "published_at": "2024-11-07T15:00:00+00:00" }, { "id": "01a0c539-5ba3-71b5-9177-a078c1d841cc", "title": "GLP1-RAs and Type 1 Diabetes: A retrospective study of incretin-based therapy use with Open Source AID.", "url": "https://www.diabettech.com/glp1-ras-and-type-1-diabetes-a-retrospective-study-of-incretin-based-therapy-use-with-open-source-aid/?utm_source=rss&utm_medium=rss&utm_campaign=glp1-ras-and-type-1-diabetes-a-retrospective-study-of-incretin-based-therapy-use-with-open-source-aid", "published_at": "2024-10-17T15:00:07+00:00" }, { "id": "01a0c539-5ba3-71b5-9177-a078c251cc54", "title": "GLP1-RAs in Type 1 Diabetes: Dosing and Pharmacokinetics", "url": "https://www.diabettech.com/glp1-ras-in-type-1-diabetes-dosing-and-pharmacokinetics/?utm_source=rss&utm_medium=rss&utm_campaign=glp1-ras-in-type-1-diabetes-dosing-and-pharmacokinetics", "published_at": "2024-10-11T14:00:05+00:00" }, { "id": "01a0c539-5ba3-71b5-9177-a078c2a9b1be", "title": "GLP1-RAs in Type 1 Diabetes: more than meets the eye?", "url": "https://www.diabettech.com/glp-1s-in-type-1-diabetes-more-than-meets-the-eye/?utm_source=rss&utm_medium=rss&utm_campaign=glp-1s-in-type-1-diabetes-more-than-meets-the-eye", "published_at": "2024-10-08T15:00:00+00:00" }, { "id": "01a0c539-5ba3-71b5-9177-a078c39db4b4", "title": "Microtech’s Linx. An Aidex sequel.", "url": "https://www.diabettech.com/microtechs-linx-an-aidex-sequel/?utm_source=rss&utm_medium=rss&utm_campaign=microtechs-linx-an-aidex-sequel", "published_at": "2024-09-28T13:41:47+00:00" }, { "id": "01a0c539-5ba3-71b5-9177-a078c46f9528", "title": "Abbott’s Takedown Shakedown – an update", "url": "https://www.diabettech.com/abbotts-takedown-shakedown-an-update/?utm_source=rss&utm_medium=rss&utm_campaign=abbotts-takedown-shakedown-an-update", "published_at": "2024-09-04T09:18:58+00:00" }, { "id": "01a0c539-5ba3-71b5-9177-a078c4b9f435", "title": "Abbott’s Takedown Shakedown. No Libre no more", "url": "https://www.diabettech.com/abbotts-takedown-shakedown-no-libre-no-more/?utm_source=rss&utm_medium=rss&utm_campaign=abbotts-takedown-shakedown-no-libre-no-more", "published_at": "2024-09-03T13:13:06+00:00" }, { "id": "01a0c539-5ba3-71b5-9177-a078c4ea071c", "title": "Dexcom’s Stelo by numbers. Could a 15 day G7 be imminent?", "url": "https://www.diabettech.com/dexcoms-stelo-by-numbers-could-a-15-day-g7-be-imminent/?utm_source=rss&utm_medium=rss&utm_campaign=dexcoms-stelo-by-numbers-could-a-15-day-g7-be-imminent", "published_at": "2024-08-28T17:30:38+00:00" }, { "id": "01a0c539-5ba3-71b5-9177-a078c598813b", "title": "Exercise, Insulin and Automation. The challenges.", "url": "https://www.diabettech.com/exercise-insulin-and-automation-the-challenges/?utm_source=rss&utm_medium=rss&utm_campaign=exercise-insulin-and-automation-the-challenges", "published_at": "2024-08-20T18:22:47+00:00" }, { "id": "01a0c539-5ba3-71b5-9177-a078c59d07f5", "title": "To patch pump or not to patch pump? That is the question…", "url": "https://www.diabettech.com/to-patch-pump-or-not-to-patch-pump-that-is-the-question/?utm_source=rss&utm_medium=rss&utm_campaign=to-patch-pump-or-not-to-patch-pump-that-is-the-question", "published_at": "2024-08-15T17:15:12+00:00" }, { "id": "01a0c539-5ba3-71b5-9177-a078c5ec9ad2", "title": "Waving the white flag? Medtronic partners with Abbott for CGM.", "url": "https://www.diabettech.com/waving-the-white-flag-medtronic-partners-with-abbott-for-cgm/?utm_source=rss&utm_medium=rss&utm_campaign=waving-the-white-flag-medtronic-partners-with-abbott-for-cgm", "published_at": "2024-08-07T16:15:14+00:00" }, { "id": "01a0c542-abe9-700c-a612-b09b2424bc60", "title": "Ypsomed Diabetes Care. What happens next?", "url": "https://www.diabettech.com/ypsomed-diabetes-care-what-happens-next/?utm_source=rss&utm_medium=rss&utm_campaign=ypsomed-diabetes-care-what-happens-next", "published_at": "2024-07-08T16:51:15+00:00" }, { "id": "01a0c542-abe9-700c-a612-b09b2424f29e", "title": "When n=1 is not enough. An initial take on the Libre2 and Libre2 Plus comparison", "url": "https://www.diabettech.com/when-n1-is-not-enough-an-initial-take-on-the-libre2-and-libre2-plus-comparison/?utm_source=rss&utm_medium=rss&utm_campaign=when-n1-is-not-enough-an-initial-take-on-the-libre2-and-libre2-plus-comparison", "published_at": "2024-06-19T14:00:51+00:00" }, { "id": "01a0c542-abe9-700c-a612-b09b24e3fc5f", "title": "The Modular Medical MODD1 insulin pump. What do we know?", "url": "https://www.diabettech.com/the-modular-medical-modd1-insulin-pump-what-do-we-know/?utm_source=rss&utm_medium=rss&utm_campaign=the-modular-medical-modd1-insulin-pump-what-do-we-know", "published_at": "2024-05-31T13:00:07+00:00" }, { "id": "01a0c542-abe9-700c-a612-b09b24f01db6", "title": "Coming soon… Libre2 and Libre2 Plus Face Off", "url": "https://www.diabettech.com/coming-soon-libre2-and-libre2-plus-face-off/?utm_source=rss&utm_medium=rss&utm_campaign=coming-soon-libre2-and-libre2-plus-face-off", "published_at": "2024-05-28T13:00:36+00:00" }, { "id": "01a0c542-abe9-700c-a612-b09b25c68844", "title": "The NHS England Hybrid Closed Loop experiment comes a step closer to implementation", "url": "https://www.diabettech.com/the-nhs-england-hybrid-closed-loop-experiment-comes-a-step-closer-to-implementation/?utm_source=rss&utm_medium=rss&utm_campaign=the-nhs-england-hybrid-closed-loop-experiment-comes-a-step-closer-to-implementation", "published_at": "2024-05-25T08:00:04+00:00" }, { "id": "01a0c542-abe9-700c-a612-b09b26688cb9", "title": "Medtrum’s Nano – an alternative patch pump", "url": "https://www.diabettech.com/medtrums-nano-an-alternative-patch-pump/?utm_source=rss&utm_medium=rss&utm_campaign=medtrums-nano-an-alternative-patch-pump", "published_at": "2024-05-16T17:07:01+00:00" }, { "id": "01a0c542-abe9-700c-a612-b09b267fde4f", "title": "Diabetes and Data. What more can we learn? Part 2.", "url": "https://www.diabettech.com/diabetes-and-data-what-more-can-we-learn-part-2/?utm_source=rss&utm_medium=rss&utm_campaign=diabetes-and-data-what-more-can-we-learn-part-2", "published_at": "2024-05-02T13:00:08+00:00" }, { "id": "01a0c542-abe9-700c-a612-b09b268c9efa", "title": "Diabetes and Data. What more can we learn? Part 1.", "url": "https://www.diabettech.com/diabetes-and-data-what-more-can-we-learn-part-1/?utm_source=rss&utm_medium=rss&utm_campaign=diabetes-and-data-what-more-can-we-learn-part-1", "published_at": "2024-04-25T13:00:48+00:00" }, { "id": "01a0c542-abe9-700c-a612-b09b271f34aa", "title": "Comparing Dexcom’s G7 and One+. Is there much difference?", "url": "https://www.diabettech.com/comparing-dexcoms-g7-and-one-is-there-much-difference/?utm_source=rss&utm_medium=rss&utm_campaign=comparing-dexcoms-g7-and-one-is-there-much-difference", "published_at": "2024-03-28T16:30:09+00:00" }, { "id": "01a0c542-abe9-700c-a612-b09b27ab8d01", "title": "The Sequel Med Tech Twiist with Tidepool Loop. Where did it come from, and what is it?", "url": "https://www.diabettech.com/the-sequel-med-tech-twiist-aid-system-with-tidepool-loop-where-did-it-come-from-and-what-is-it/?utm_source=rss&utm_medium=rss&utm_campaign=the-sequel-med-tech-twiist-aid-system-with-tidepool-loop-where-did-it-come-from-and-what-is-it", "published_at": "2024-03-22T08:15:04+00:00" }, { "id": "01a0c54b-856e-706c-ac03-fb3d7ca79009", "title": "New technologies for MDI. Have Roche and Medtronic missed a trick?", "url": "https://www.diabettech.com/new-technologies-for-mdi-have-roche-and-medtronic-missed-a-trick/?utm_source=rss&utm_medium=rss&utm_campaign=new-technologies-for-mdi-have-roche-and-medtronic-missed-a-trick", "published_at": "2024-03-20T13:00:17+00:00" }, { "id": "01a0c54b-856e-706c-ac03-fb3d7d782f69", "title": "Medtronic Simplera. Is it really the “Simple Era”?", "url": "https://www.diabettech.com/medtronic-simplera-is-it-really-the-simple-era/?utm_source=rss&utm_medium=rss&utm_campaign=medtronic-simplera-is-it-really-the-simple-era", "published_at": "2024-03-17T12:33:25+00:00" }, { "id": "01a0c54b-856e-706c-ac03-fb3d7e41ed34", "title": "Welcome to the Wild, Wild West: the CGM head-to-head study", "url": "https://www.diabettech.com/welcome-to-the-wild-wild-west-the-cgm-head-to-head-study/?utm_source=rss&utm_medium=rss&utm_campaign=welcome-to-the-wild-wild-west-the-cgm-head-to-head-study", "published_at": "2024-03-05T10:30:46+00:00" }, { "id": "01a0c54b-856e-706c-ac03-fb3d7f01611f", "title": "Medtrum Nano CGM… A tale of two sensors", "url": "https://www.diabettech.com/medtrum-nano-cgm-a-tale-of-two-sensors/?utm_source=rss&utm_medium=rss&utm_campaign=medtrum-nano-cgm-a-tale-of-two-sensors", "published_at": "2024-02-20T13:00:51+00:00" }, { "id": "01a0c54b-856e-706c-ac03-fb3d7fa3eaae", "title": "Sinocare’s iCan i3 CGM. And another one…", "url": "https://www.diabettech.com/sinocares-ican-i3-cgm-and-another-one/?utm_source=rss&utm_medium=rss&utm_campaign=sinocares-ican-i3-cgm-and-another-one", "published_at": "2024-02-07T11:00:25+00:00" }, { "id": "01a0c54b-856e-706c-ac03-fb3d8016e71f", "title": "A new CGM from Roche? What do we know?", "url": "https://www.diabettech.com/a-new-cgm-from-roche-what-do-we-know/?utm_source=rss&utm_medium=rss&utm_campaign=a-new-cgm-from-roche-what-do-we-know", "published_at": "2024-01-30T11:30:17+00:00" }, { "id": "01a0c54b-856e-706c-ac03-fb3d8054ceea", "title": "SiBionics GS1 CGM: a deep dive", "url": "https://www.diabettech.com/sibionics-gs1-cgm-a-deep-dive/?utm_source=rss&utm_medium=rss&utm_campaign=sibionics-gs1-cgm-a-deep-dive", "published_at": "2024-01-21T18:00:01+00:00" }, { "id": "01a0c54b-856e-706c-ac03-fb3d80674e19", "title": "NICE TA943:Hybrid closed loop systems for managing blood glucose levels in type 1 diabetes. What you need to know.", "url": "https://www.diabettech.com/nice-ta943hybrid-closed-loop-systems-for-managing-blood-glucose-levels-in-type-1-diabetes-what-you-need-to-know/?utm_source=rss&utm_medium=rss&utm_campaign=nice-ta943hybrid-closed-loop-systems-for-managing-blood-glucose-levels-in-type-1-diabetes-what-you-need-to-know", "published_at": "2023-12-19T18:15:20+00:00" }, { "id": "01a0c54b-856e-706c-ac03-fb3d8131d28f", "title": "Zealand Pharma. The other Danish pharmaceutical company doing interesting things", "url": "https://www.diabettech.com/zealand-pharma-the-other-danish-pharmaceutical-company-doing-interesting-things/?utm_source=rss&utm_medium=rss&utm_campaign=zealand-pharma-the-other-danish-pharmaceutical-company-doing-interesting-things", "published_at": "2023-12-18T20:42:20+00:00" }, { "id": "01a0c54b-856e-706c-ac03-fb3d81a6e1ba", "title": "Yet another n=1 CGM face off….", "url": "https://www.diabettech.com/yet-another-n1-cgm-face-off/?utm_source=rss&utm_medium=rss&utm_campaign=yet-another-n1-cgm-face-off", "published_at": "2023-12-04T17:30:44+00:00" }, { "id": "01a0c553-cfe4-7165-80b5-0716db3f0887", "title": "Commercial AID or Open Source? Some things to consider…", "url": "https://www.diabettech.com/commercial-aid-or-open-source-some-things-to-consider/?utm_source=rss&utm_medium=rss&utm_campaign=commercial-aid-or-open-source-some-things-to-consider", "published_at": "2023-11-30T19:53:25+00:00" }, { "id": "01a0c553-cfe4-7165-80b5-0716dc36304a", "title": "A close up view of Libre CGM data via Diabox…", "url": "https://www.diabettech.com/a-close-up-view-of-libre-cgm-data-via-diabox/?utm_source=rss&utm_medium=rss&utm_campaign=a-close-up-view-of-libre-cgm-data-via-diabox", "published_at": "2023-11-14T06:26:33+00:00" }, { "id": "01a0c553-cfe4-7165-80b5-0716dc9ccc36", "title": "And another one! SiBionics CGM enters the fray.", "url": "https://www.diabettech.com/yet-another-new-cgm-first-impressions-of-sibionics-offering/?utm_source=rss&utm_medium=rss&utm_campaign=yet-another-new-cgm-first-impressions-of-sibionics-offering", "published_at": "2023-09-26T16:47:19+00:00" }, { "id": "01a0c553-cfe4-7165-80b5-0716dce9f6e5", "title": "Nightscout as a service. A legal minefield?", "url": "https://www.diabettech.com/nightscout-as-a-service-a-legal-minefield/?utm_source=rss&utm_medium=rss&utm_campaign=nightscout-as-a-service-a-legal-minefield", "published_at": "2023-09-12T15:47:12+00:00" }, { "id": "01a0c553-cfe4-7165-80b5-0716ddc13abe", "title": "Continuous Glucose Monitoring – clinical trial quality data", "url": "https://www.diabettech.com/continuous-glucose-monitoring-clinical-trial-quality-data/?utm_source=rss&utm_medium=rss&utm_campaign=continuous-glucose-monitoring-clinical-trial-quality-data", "published_at": "2023-08-14T19:35:04+00:00" }, { "id": "01a0c553-cfe4-7165-80b5-0716ddf16b97", "title": "The world’s first CKM, with some data", "url": "https://www.diabettech.com/the-worlds-first-ckm-with-some-data/?utm_source=rss&utm_medium=rss&utm_campaign=the-worlds-first-ckm-with-some-data", "published_at": "2023-08-02T12:13:48+00:00" }, { "id": "01a0c553-cfe4-7165-80b5-0716decbb6ce", "title": "A lesson in how not to roll out real-time CGM to an existing system", "url": "https://www.diabettech.com/a-lesson-in-how-not-to-roll-out-real-time-cgm-to-an-existing-system/?utm_source=rss&utm_medium=rss&utm_campaign=a-lesson-in-how-not-to-roll-out-real-time-cgm-to-an-existing-system", "published_at": "2023-07-26T16:56:11+00:00" }, { "id": "01a0c553-cfe4-7165-80b5-0716dfb7c454", "title": "Continuous Ketone Monitoring – a world’s first from SiBio?", "url": "https://www.diabettech.com/continuous-ketone-monitoring-a-worlds-first-from-sibio/?utm_source=rss&utm_medium=rss&utm_campaign=continuous-ketone-monitoring-a-worlds-first-from-sibio", "published_at": "2023-07-17T19:10:53+00:00" }, { "id": "01a0c553-cfe4-7165-80b5-0716e0457944", "title": "And another one? The final poor CGM Smartwatch", "url": "https://www.diabettech.com/and-another-one-the-final-poor-cgm-smartwatch/?utm_source=rss&utm_medium=rss&utm_campaign=and-another-one-the-final-poor-cgm-smartwatch", "published_at": "2023-07-05T16:50:37+00:00" }, { "id": "01a0c553-cfe4-7165-80b5-0716e08ad6e3", "title": "Glastonbury 2023: Rick Astley and The Blossoms play the Smiths…", "url": "https://www.diabettech.com/glastonbury-2023-rick-astley-and-the-blossoms-play-the-smiths/?utm_source=rss&utm_medium=rss&utm_campaign=glastonbury-2023-rick-astley-and-the-blossoms-play-the-smiths", "published_at": "2023-06-27T21:09:21+00:00" }, { "id": "01a0c55c-341c-7293-bcb2-d26902380194", "title": "Novo Nordisk acquisition of Biocorp. A big deal in the Smartpen world?", "url": "https://www.diabettech.com/novo-nordisk-acquisition-of-biocorp-a-big-deal-in-the-smartpen-world/?utm_source=rss&utm_medium=rss&utm_campaign=novo-nordisk-acquisition-of-biocorp-a-big-deal-in-the-smartpen-world", "published_at": "2023-06-06T16:45:34+00:00" }, { "id": "01a0c55c-341c-7293-bcb2-d2690252546f", "title": "Non-invasive CGM watches. Is this a Dreamcatcher moment?", "url": "https://www.diabettech.com/non-invasive-cgm-watches-is-this-a-dreamcatcher-moment/?utm_source=rss&utm_medium=rss&utm_campaign=non-invasive-cgm-watches-is-this-a-dreamcatcher-moment", "published_at": "2023-06-05T16:41:04+00:00" }, { "id": "01a0c55c-341c-7293-bcb2-d26902f7f216", "title": "Experiments with stepcounts. An n=1 experience", "url": "https://www.diabettech.com/experiments-with-stepcounts-an-n1-experience/?utm_source=rss&utm_medium=rss&utm_campaign=experiments-with-stepcounts-an-n1-experience", "published_at": "2023-05-24T16:48:25+00:00" }, { "id": "01a0c55c-341c-7293-bcb2-d26903c91014", "title": "Cheap smartwatches with CGM… What do we think?", "url": "https://www.diabettech.com/cheap-smartwatches-with-cgm-what-do-we-think/?utm_source=rss&utm_medium=rss&utm_campaign=cheap-smartwatches-with-cgm-what-do-we-think", "published_at": "2023-05-09T17:14:45+00:00" }, { "id": "01a0c55c-341c-7293-bcb2-d2690460fd72", "title": "Everybody’s moving – integrating stepcounts into Open Source Automated Insulin Delivery", "url": "https://www.diabettech.com/everybodys-moving-integrating-stepcounts-into-open-source-automated-insulin-delivery/?utm_source=rss&utm_medium=rss&utm_campaign=everybodys-moving-integrating-stepcounts-into-open-source-automated-insulin-delivery", "published_at": "2023-05-02T21:00:33+00:00" }, { "id": "01a0c55c-341c-7293-bcb2-d26904ba691e", "title": "Glucagon me… n=1 experiments with microbolusing glucagon part 2: quantifying use", "url": "https://www.diabettech.com/glucagon-me-n1-experiments-with-microbolusing-glucagon-part-2-quantifying-use/?utm_source=rss&utm_medium=rss&utm_campaign=glucagon-me-n1-experiments-with-microbolusing-glucagon-part-2-quantifying-use", "published_at": "2023-04-05T05:50:14+00:00" }, { "id": "01a0c55c-341c-7293-bcb2-d269057eb0ba", "title": "Glucagon me… n=1 experiments with microbolusing Glucagon part 1: setting a baseline", "url": "https://www.diabettech.com/glucagon-me-n1-experiments-with-microbolusing-glucagon-part-1-setting-a-baseline/?utm_source=rss&utm_medium=rss&utm_campaign=glucagon-me-n1-experiments-with-microbolusing-glucagon-part-1-setting-a-baseline", "published_at": "2023-04-04T17:56:48+00:00" }, { "id": "01a0c55c-341c-7293-bcb2-d26905b9cd29", "title": "Eyecare or iCare? A revolution in the eye screening world.", "url": "https://www.diabettech.com/eyecare-or-icare-a-revolution-in-the-eye-screening-world/?utm_source=rss&utm_medium=rss&utm_campaign=eyecare-or-icare-a-revolution-in-the-eye-screening-world", "published_at": "2023-03-03T15:02:00+00:00" }, { "id": "01a0c55c-341c-7293-bcb2-d26906507580", "title": "How far are we from fully closed loop? News from ATTD 2023", "url": "https://www.diabettech.com/how-far-are-we-from-fully-closed-loop-news-from-attd-2023/?utm_source=rss&utm_medium=rss&utm_campaign=how-far-are-we-from-fully-closed-loop-news-from-attd-2023", "published_at": "2023-02-28T15:00:15+00:00" } ] posts Claim your blog
Back to diabettech.com
Blog · corpus.blog/blogs/diabettech.com/posts

diabettech.com

diabettech.com

2026

Zucara’s ZT-01: what could taking the brake off glucagon do?original ↗
23 Sept 2026
More Bolus, Less Basal: What Happens When oref Loops Run More Frequentlyoriginal ↗
18 Sept 2026
Your CGM Knows You Ate. It Can’t Tell What You Ate.original ↗
15 Sept 2026
Beyond Carb Counting: Boost’s Evolution — and the Limits of “Fully Closed Loop”original ↗
7 Sept 2026
Bolt AI into your loop and you might just have become a medical device manufactureroriginal ↗
28 Aug 2026
The world’s first digital endo that asks AI to fix your AID settings, and why you should keep your money.original ↗
24 Aug 2026
A world of pure imagination: AI, diabetes and the data we can’t get atoriginal ↗
6 Aug 2026
Why is the cheese sandwich the downfall of AI carb counting, even with “3D scanning”?original ↗
11 Jun 2026
The Libre Duo. A platform prototype to move care from the hospital to the home?original ↗
1 Jun 2026
Five AI models, three users, one finding: the settings came from the textbook, not the dataoriginal ↗
22 Apr 2026
I Asked AI to Count My Carbs 27,000 Times. It Couldn’t Give Me the Same Answer Twice.original ↗
15 Apr 2026
The Daily Bolus: The Triple Agonist Showdown & Surprising GLP-1 Wins in Type 1 Diabetesoriginal ↗
26 Mar 2026
100% Insulin Independence: Why Eledon’s Breakthrough is a Pillar, Not a Cureoriginal ↗
3 Mar 2026
Explore a Decade of Diabetes Insights with Diabettech AIoriginal ↗
25 Feb 2026
The Daily Bolus: Red Cell Sponges, Microbiome Signatures, and Cyborg Cellsoriginal ↗
20 Feb 2026
Now We Know What a Type 1 Cure Could Look Likeoriginal ↗
14 Feb 2026
The Daily Bolus: Retinopathy Pills, Diabetes Risk Watches, and Immune Fixes for Insulin Resistanceoriginal ↗
14 Feb 2026
The Daily Bolus: Early Warnings, Genetic Cloaks, and the Seven-Year Shieldoriginal ↗
5 Feb 2026
The Daily Bolus: Mechanism over metrics, biology over dashboardsoriginal ↗
30 Jan 2026
The Daily Bolus: Et tu, B Cells?original ↗
21 Jan 2026
What If Type 1 Diabetes Was Treatable — If You Found It Early Enough?original ↗
19 Jan 2026
The Daily Bolus: What happened over the weekend?original ↗
19 Jan 2026
A “twiist” of Fate: Why Sequel is Moving Beyond Tidepool to Embrace Diabelooporiginal ↗
15 Jan 2026
The Daily Bolus: Interoperability, AI, and Enhanced Glycemic Insightsoriginal ↗
13 Jan 2026
Introducing The Daily Bolus: Parsing the Signal from the Noiseoriginal ↗
13 Jan 2026
ChatGPT Health: Promise, Practicality, and the Reality for People with Diabetesoriginal ↗
12 Jan 2026

2025

Unauthorised Use of Nine Sensor Samba Data in Commercial Marketingoriginal ↗
31 Oct 2025
A pump update and then… Something changed!original ↗
23 Sept 2025
The Nine Sensor Samba: How do the Consensus Error Grids stack up?original ↗
15 Sept 2025
The nine sensor samba: Results revealedoriginal ↗
9 Sept 2025
The Nine Sensor Samba — A Sneak Peek at Simultaneous CGM Testingoriginal ↗
15 Aug 2025
Beyond Snaq-qing. Digesting your glucose patterns.original ↗
12 Aug 2025
Snaq. A diabetes AI to help you carb count. Badly.original ↗
8 Aug 2025
In conversation with… Unpacking the “Why” Behind the Errorsoriginal ↗
21 Jul 2025
In conversation with… File uploads and interpretation. Where the wheels fall off!original ↗
18 Jul 2025
In Conversation with…. Reviewing user data and system settings using AIoriginal ↗
14 Jul 2025
In Conversation with…. Carb Counting with AI: A Deep Dive into How Different Models Stack Uporiginal ↗
7 Jul 2025
In conversation with… Factual questions for Large Language Modelsoriginal ↗
21 Jun 2025
In conversation with… the questionsoriginal ↗
19 Jun 2025
In conversation with…. How effective are large language models at giving diabetes advice?original ↗
13 Jun 2025
Beyond Blood Sugar: Could incretins shield against diabetes complications?original ↗
11 Jun 2025
Medtronic, Ypsomed, and the Diabetes Device Shake-Up: Spin-Offs, Strategy, and the Future of Diabetes Techoriginal ↗
22 May 2025
It’s been a while…original ↗
10 May 2025
MARD wars. More craziness in the world of CGM marketing from ATTDoriginal ↗
26 Mar 2025
It’s ATTD again, and here’s another CGM accuracy study…original ↗
20 Mar 2025
Holidays. Even from T1D?original ↗
2 Mar 2025
CGM: Is “More” always better? Abbott’s Libres. More Data – part 2original ↗
5 Feb 2025
CGM: Is “More” always better? Abbott’s Libres. More Data – part 1original ↗
4 Feb 2025
CGM: Is “More” always better? Dexcom’s G7. More Accurateoriginal ↗
1 Feb 2025
CGM: Is “More” always better?original ↗
30 Jan 2025

2024

Location, location, location. Does cannula site affect AID performance?original ↗
7 Nov 2024
GLP1-RAs and Type 1 Diabetes: A retrospective study of incretin-based therapy use with Open Source AID.original ↗
17 Oct 2024
GLP1-RAs in Type 1 Diabetes: Dosing and Pharmacokineticsoriginal ↗
11 Oct 2024
GLP1-RAs in Type 1 Diabetes: more than meets the eye?original ↗
8 Oct 2024
Microtech’s Linx. An Aidex sequel.original ↗
28 Sept 2024
Abbott’s Takedown Shakedown – an updateoriginal ↗
4 Sept 2024
Abbott’s Takedown Shakedown. No Libre no moreoriginal ↗
3 Sept 2024
Dexcom’s Stelo by numbers. Could a 15 day G7 be imminent?original ↗
28 Aug 2024
Exercise, Insulin and Automation. The challenges.original ↗
20 Aug 2024
To patch pump or not to patch pump? That is the question…original ↗
15 Aug 2024
Waving the white flag? Medtronic partners with Abbott for CGM.original ↗
7 Aug 2024
Ypsomed Diabetes Care. What happens next?original ↗
8 Jul 2024
When n=1 is not enough. An initial take on the Libre2 and Libre2 Plus comparisonoriginal ↗
19 Jun 2024
The Modular Medical MODD1 insulin pump. What do we know?original ↗
31 May 2024
Coming soon… Libre2 and Libre2 Plus Face Offoriginal ↗
28 May 2024
The NHS England Hybrid Closed Loop experiment comes a step closer to implementationoriginal ↗
25 May 2024
Medtrum’s Nano – an alternative patch pumporiginal ↗
16 May 2024
Diabetes and Data. What more can we learn? Part 2.original ↗
2 May 2024
Diabetes and Data. What more can we learn? Part 1.original ↗
25 Apr 2024
Comparing Dexcom’s G7 and One+. Is there much difference?original ↗
28 Mar 2024
The Sequel Med Tech Twiist with Tidepool Loop. Where did it come from, and what is it?original ↗
22 Mar 2024
New technologies for MDI. Have Roche and Medtronic missed a trick?original ↗
20 Mar 2024
Medtronic Simplera. Is it really the “Simple Era”?original ↗
17 Mar 2024
Welcome to the Wild, Wild West: the CGM head-to-head studyoriginal ↗
5 Mar 2024
Medtrum Nano CGM… A tale of two sensorsoriginal ↗
20 Feb 2024
Sinocare’s iCan i3 CGM. And another one…original ↗
7 Feb 2024
A new CGM from Roche? What do we know?original ↗
30 Jan 2024
SiBionics GS1 CGM: a deep diveoriginal ↗
21 Jan 2024

2023

NICE TA943:Hybrid closed loop systems for managing blood glucose levels in type 1 diabetes. What you need to know.original ↗
19 Dec 2023
Zealand Pharma. The other Danish pharmaceutical company doing interesting thingsoriginal ↗
18 Dec 2023
Yet another n=1 CGM face off….original ↗
4 Dec 2023
Commercial AID or Open Source? Some things to consider…original ↗
30 Nov 2023
A close up view of Libre CGM data via Diabox…original ↗
14 Nov 2023
And another one! SiBionics CGM enters the fray.original ↗
26 Sept 2023
Nightscout as a service. A legal minefield?original ↗
12 Sept 2023
Continuous Glucose Monitoring – clinical trial quality dataoriginal ↗
14 Aug 2023
The world’s first CKM, with some dataoriginal ↗
2 Aug 2023
A lesson in how not to roll out real-time CGM to an existing systemoriginal ↗
26 Jul 2023
Continuous Ketone Monitoring – a world’s first from SiBio?original ↗
17 Jul 2023
And another one? The final poor CGM Smartwatchoriginal ↗
5 Jul 2023
Glastonbury 2023: Rick Astley and The Blossoms play the Smiths…original ↗
27 Jun 2023
Novo Nordisk acquisition of Biocorp. A big deal in the Smartpen world?original ↗
6 Jun 2023
Non-invasive CGM watches. Is this a Dreamcatcher moment?original ↗
5 Jun 2023
Experiments with stepcounts. An n=1 experienceoriginal ↗
24 May 2023
Cheap smartwatches with CGM… What do we think?original ↗
9 May 2023
Everybody’s moving – integrating stepcounts into Open Source Automated Insulin Deliveryoriginal ↗
2 May 2023
Glucagon me… n=1 experiments with microbolusing glucagon part 2: quantifying useoriginal ↗
5 Apr 2023
Glucagon me… n=1 experiments with microbolusing Glucagon part 1: setting a baselineoriginal ↗
4 Apr 2023
Eyecare or iCare? A revolution in the eye screening world.original ↗
3 Mar 2023
How far are we from fully closed loop? News from ATTD 2023original ↗
28 Feb 2023
Next